TWST
Twist Bioscience Corporation·Healthcare
59.81
6.367%(+3.58)
Market ClosedLast Updated: — ET
52W L: $23.3052W H: $61.61
TWST NEWS
defenseworld.net
3d ago
Adam Laponis Sells 2,597 Shares of Twist Bioscience (NASDAQ:TWST) Stock
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) CFO Adam Laponis sold 2,597 shares of the company's stock in a transaction that occurred on Thursday, April 9th. The shares were sold at an average price of $49.89, for a total value of $129,564.33. Following the completion of the transaction, the chief financial officer directly owned
defenseworld.net
Apr 6
Twist Bioscience (NASDAQ:TWST) Director Sells $51,000.00 in Stock
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) Director Melissa Starovasnik sold 1,000 shares of the firm's stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $51.00, for a total transaction of $51,000.00. Following the completion of the transaction, the director directly owned 25,722 shares in the
defenseworld.net
Apr 5
SG Americas Securities LLC Acquires 59,500 Shares of Twist Bioscience Corporation $TWST
SG Americas Securities LLC lifted its holdings in Twist Bioscience Corporation (NASDAQ: TWST) by 350.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 76,484 shares of the company's stock after acquiring an additional 59,500 shares during the quarter. SG Americas Securities LLC
defenseworld.net
Apr 3
Twist Bioscience Corporation (NASDAQ:TWST) Receives Average Rating of “Moderate Buy” from Analysts
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the nine brokerages that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating and seven have given a buy rating to the company. The average 12 month target price
defenseworld.net
Mar 28
Zenas BioPharma (NASDAQ:ZBIO) versus Twist Bioscience (NASDAQ:TWST) Critical Analysis
Twist Bioscience (NASDAQ: TWST - Get Free Report) and Zenas BioPharma (NASDAQ: ZBIO - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability. Analyst Ratings This is a summary of current
seekingalpha.com
Mar 10
Twist Bioscience Corporation (TWST) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Twist Bioscience Corporation (TWST) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
